Kodiak Sciences Funding & Investors
Kodiak Sciences Inc. operates as a clinical stage biopharmaceutical company. The Company specializes in novel therapeutics to treat chronic and high-prevalence retinal diseases. Kodiak Sciences serves customers in the United States.
kodiak.comTotal Amount Raised: $1,031,230,016
Kodiak Sciences Funding Rounds
Post Ipo Equity
$645,000,000
Post Ipo Equity
$317,400,000
Convertible Note
$33,000,000
Convertible Note Investors
Rivas CapitalArrowMark PartnersPerceptive AdvisorsSeries B
$34,000,000
Series Unknown
$1,830,000
Funding info provided by Diffbot.